ANAB
ANAPTYSBIO, INC
Latest Form 4:Sale$1.2MbySchmid John P. (Director) · filed Apr 1, 2026
ANAPTYSBIO, INC (ANAB) has 28 SEC Form 4 filings (70 transaction rows) in the rolling window, disclosed by 7 distinct insiders. Most recent filing: Jun 17, 2026.
The most active filer is CHIEF LEGAL OFFICER LOUMEAU ERIC J with 9 filings. Insiders have net sold $7.8M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Daniel R. Faga
- Employees:136
- HQ:San Diego, CA, US
- IPO:2017-01-26
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$9.7M
reported sales (SEC code S)
Unique Insiders
7
in the rolling window
Market Cap
$1.6B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Schmid John P.First filing | Director | Sale | 30,968 | $1.2M | Apr 1 | SEC ↗ |
| President, CEO | Sale | 26,519 | $1.1M | Mar 27 | SEC ↗ | |
| CHIEF LEGAL OFFICER | Sale | 15,000 | $540K | Feb 13 | SEC ↗ | |
Marquet MagdaFirst filing | Director | Sale | 16,500 | $531K | Jan 16 | SEC ↗ |
| Chief Medical Officer | Sale | 5,475 | $163K | Jan 9 | SEC ↗ | |
| CHIEF LEGAL OFFICER | Sale | 3,315 | $99K | Jan 9 | SEC ↗ | |
| CHIEF FINANCIAL OFFICER | Sale | 3,773 | $112K | Jan 9 | SEC ↗ | |
| President, CEO | Sale | 21,422 | $639K | Jan 9 | SEC ↗ | |
| CHIEF LEGAL OFFICER | Sale | 14,460 | $439K | Jan 8 | SEC ↗ | |
| CHIEF FINANCIAL OFFICER | Sale | 2,862 | $86K | Jan 8 | SEC ↗ | |
| Chief Medical Officer | Sale | 3,353 | $101K | Jan 8 | SEC ↗ | |
| President, CEO | Sale | 13,803 | $415K | Jan 8 | SEC ↗ | |
| CHIEF LEGAL OFFICER | Sale | 4,475 | $129K | Jan 6 | SEC ↗ | |
| Chief Medical Officer | Sale | 6,329 | $183K | Jan 6 | SEC ↗ | |
Faga DanielFirst filing | President, CEO | Sale | 22,964 | $662K | Jan 6 | SEC ↗ |
| CHIEF FINANCIAL OFFICER | Sale | 5,045 | $145K | Jan 6 | SEC ↗ | |
| CHIEF LEGAL OFFICER | Sale | 15,000 | $510K | Dec 23 | SEC ↗ | |
Lizzul Paul F.First filing | Chief Medical Officer | Sale | 2,250 | $75K | Dec 23 | SEC ↗ |
| CHIEF FINANCIAL OFFICER | Sale | 15,000 | $500K | Dec 23 | SEC ↗ | |
Ware J. AnthonyFirst filing | Director | Sale | 5,850 | $193K | Dec 23 | SEC ↗ |
| CHIEF LEGAL OFFICER | Sale | 18,751 | $561K | Dec 18 | SEC ↗ | |
| CHIEF LEGAL OFFICER | Sale | 15,000 | $460K | Dec 18 | SEC ↗ | |
| CHIEF LEGAL OFFICER | Sale | 212 | $7K | Dec 18 | SEC ↗ | |
MULROY DENNISFirst filing | CHIEF FINANCIAL OFFICER | Sale | 23,588 | $705K | Dec 18 | SEC ↗ |
LOUMEAU ERIC JFirst filing | CHIEF LEGAL OFFICER | Sale | 12,360 | $239K | Oct 1 | SEC ↗ |
Related companies
ANAPTYSBIO, INC is in the Healthcare sector.